Prostate Cancer - Results from #28400

CURy 2011 - PSA, SNP and other new markers - Slide Presentation March 24, 2011

CURy 2011 - HistoScanning™ Better imaging for prostate cancer? - Slide Presentation March 24, 2011

CURy 2011 - Clinical development of a new GnRH blocker - Slide Presentation March 24, 2011

CURy 2011 - Locally advanced PCa:The role of surgery in combination treatments - Slide Presentation March 24, 2011

CURy 2011 - Androgen deprivation with radiation: When? For how long? - Slide Presentation March 24, 2011

CURy 2011 - Which patients will benefit from a GnRH blocker? - Slide Presentation March 24, 2011

CURy 2011 - GnRH-receptor blockers: A new era for GnRH analogues? - Slide Presentation March 24, 2011

Patients' experiences of high-dose rate brachytherapy boost for prostate cancer using an inpatient protocol - Abstract March 23, 2011

Predictors of the use of supplemental androgen suppression therapy and external beam radiation in men with high-risk prostate cancer undergoing brachytherapy in community practice - Abstract March 23, 2011

Urological cancer care pathways: Development and use in the context of systematic reviews and clinical practice guidelines - Abstract March 23, 2011

Editor's Commentary - Risk stratification and validation of prostate specific antigen density as independent predictor of progression in men with low risk prostate cancer during active surveillance March 23, 2011

CURy 2011 - Prostate biopsy: Update 2011 - Slide Presentation March 23, 2011

CURy 2011 - Interest of multi-parametric MRI in early prostate cancer - Slide Presentation March 23, 2011

CURy 2011 - Pathological basis for focal therapy - Slide Presentation March 23, 2011

Improvement of prostate cancer detection by integrating the PSA test with miRNA expression profiling - Abstract March 22, 2011

The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapy - Abstract March 22, 2011

Moderate dose escalation with single-fraction high-dose rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-Year outcome of the first 100 consecutively treated patients - Abstract March 22, 2011

Definition of the CTV prostate in CT and MRI by using CT-MRI image fusion in IMRT planning for prostate cancer - Abstract March 22, 2011

The example of CaPSURE: Lessons learned from a national disease registry - Abstract March 22, 2011

Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology - Abstract March 22, 2011

Page 1421 of 1436